Table 3—

HR (95% CI) for death from stroke corresponding to a 1-SD increase in FPG or 2-h plasma glucose levels fitted in the model separately

Adjustment*MenWomenTotal
n11,1209,39020,510
Model 1Age, study, BMI, total cholesterol
    FPG1.04 (0.85–1.27)1.54 (1.26–1.90)1.18 (1.03–1.35)
    2-h plasma glucose1.21 (1.06–1.38)1.31 (1.07–1.61)1.25 (1.12–1.40)
Model 2Model 1 + smoking
    FPG1.04 (0.86–1.27)1.56 (1.26–1.92)1.27 (1.14–1.42)
    2-h plasma glucose1.23 (1.08–1.40)1.34 (1.09–1.65)1.18 (1.03–1.36)
Model 3Model 2 + hypertension
    FPG1.02 (0.83–1.25)1.52 (1.22–1.88)1.16 (1.00–1.33)
    2-h plasma glucose1.21 (1.06–1.38)1.31 (1.06–1.61)1.25 (1.12–1.40)
χ2 for FPG, 1 df (P)3.29 (0.07)4.08 (0.04)0.57 (0.45)
χ2 for 2-h PG, 1 df (P)10.12 (0.001)0.01 (0.94)10.45 (0.001)
  • χ2 indicates the changes in the model prediction when FPG or 2-hPG was removed from the model where both were fitted simultaneously. Subjects with diagnosed diabetes were excluded.

  • *

    * Adjusted for sex when men and women are combined.

  • SD = 1.3 for FPG and SD = 2.7 for 2-h plasma glucose.